Related Experiment Video
Updated: May 1, 2026

09:16
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
6.6K
Clinical characteristics and prognosis of therapy-related acute myeloid leukemia patients with RUNX1::RUNX1T1
Yu-Han Chang1, Guang-Hui Chang1, Hai-Tao Gao1
1Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Peking University, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
BMC Cancer
|April 30, 2026
Abstract
No abstract available in PubMed .

